HK Stock MarketDetailed Quotes

02161 JBM HEALTHCARE

Watchlist

1.580
+0.170+12.06%

Market Closed Nov 22 16:08 CST

1.30BMarket Cap7.94P/E (TTM)

JBM HEALTHCARE Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q6)Sep 30, 2023

(FY)Mar 31, 2023

(Q6)Sep 30, 2022

(FY)Mar 31, 2022

(Q6)Sep 30, 2021

(FY)Mar 31, 2021

(Q6)Sep 30, 2020

(FY)Mar 31, 2020

(FY)Mar 31, 2019

Cash flow from operating activities

Earning before tax

114.43%164.89M

----

150.12%76.9M

----

-26.24%30.75M

----

-22.76%41.68M

----

-22.74%53.97M

34.79%69.85M

Profit adjustment

Interest (income) - adjustment

-180.15%-762K

----

-1,411.11%-272K

----

89.71%-18K

----

97.03%-175K

----

-157.07%-5.89M

-99.65%-2.29M

Attributable subsidiary (profit) loss

-57.73%817K

----

7.93%1.93M

----

51.01%1.79M

----

140.03%1.19M

----

37.21%-2.96M

---4.72M

Impairment and provisions:

----

--2.5M

----

--2.6M

-Impairment of trade receivables (reversal)

----

--2.6M

-Other impairments and provisions

----

--2.5M

----

Asset sale loss (gain):

49.13%-4.46M

----

-67,592.31%-8.77M

----

-93.40%13K

----

-16.17%197K

----

--235K

----

-Loss (gain) from sale of subsidiary company

---4.47M

----

-Loss (gain) on sale of property, machinery and equipment

-96.03%5K

----

869.23%126K

----

-93.40%13K

----

-16.17%197K

----

--235K

----

-Loss (gain) from selling other assets

----

---8.9M

----

Depreciation and amortization:

6.62%46.52M

----

-8.69%43.63M

----

9.59%47.78M

----

21.58%43.6M

----

20.83%35.86M

-0.47%29.68M

-Depreciation

6.62%46.52M

----

-8.69%43.63M

----

9.59%47.78M

----

21.58%43.6M

----

20.83%35.86M

-0.47%29.68M

Financial expense

3.52%8.5M

----

28.13%8.21M

----

-13.52%6.41M

----

776.80%7.41M

----

-39.21%845K

-19.79%1.39M

Special items

3,469.57%9.03M

----

--253K

----

Operating profit before the change of operating capital

84.23%224.53M

----

36.60%121.88M

----

-4.98%89.22M

----

14.44%93.9M

----

-14.98%82.05M

17.45%96.51M

Change of operating capital

Inventory (increase) decrease

-453.48%-37.02M

----

-4,810.56%-6.69M

----

-99.10%142K

----

172.81%15.76M

----

-1,748.74%-21.65M

-72.11%1.31M

Accounts receivable (increase)decrease

-162.89%-11.73M

----

680.21%18.65M

----

85.65%-3.21M

----

15.78%-22.4M

----

26.92%-26.6M

-1,124.18%-36.4M

Accounts payable increase (decrease)

54.79%35.99M

----

352.50%23.25M

----

45.57%-9.21M

----

-176.07%-16.92M

----

668.68%22.24M

-71.30%2.89M

Cash from business operations

34.81%211.77M

-1.71%62.91M

104.17%157.09M

485.01%64.01M

9.38%76.94M

-79.41%10.94M

25.51%70.35M

--53.14M

-12.86%56.05M

-31.56%64.32M

Other taxs

-79.18%-20.56M

-27.68%-2.87M

32.30%-11.47M

12.12%-2.25M

-46.20%-16.95M

-22.34%-2.56M

34.74%-11.59M

---2.09M

-139.85%-17.76M

36.60%-7.41M

Net cash from operations

31.32%191.22M

-2.78%60.04M

142.71%145.62M

636.63%61.76M

2.11%60M

-83.58%8.38M

53.47%58.76M

--51.05M

-32.73%38.29M

-30.85%56.91M

Cash flow from investment activities

Interest received - investment

180.15%762K

7,457.14%529K

1,411.11%272K

-41.67%7K

-89.71%18K

-90.77%12K

26.81%175K

--130K

500.00%138K

--23K

Sale of fixed assets

288.10%163K

----

--42K

--31K

----

-97.64%11K

273.60%467K

Purchase of fixed assets

-25.59%-10.21M

-140.37%-9.57M

-15.23%-8.13M

-13.41%-3.98M

69.26%-7.06M

80.77%-3.51M

-407.58%-22.96M

---18.26M

50.49%-4.52M

13.51%-9.14M

Sale of subsidiaries

--17.6M

----

Acquisition of subsidiaries

----

--1.86M

----

127.95%5.26M

---18.82M

Cash on investment

----

-61.06%-823K

----

69.36%-511K

---1.67M

----

Other items in the investment business

----

249.52%42.52M

42.99%-28.44M

Net cash from investment operations

222.51%8.31M

-129.28%-9.05M

10.17%-6.78M

1.65%-3.95M

69.12%-7.55M

79.74%-4.01M

-156.34%-24.45M

---19.8M

177.65%43.4M

7.33%-55.9M

Net cash before financing

43.72%199.53M

-11.79%51M

164.72%138.83M

1,222.07%57.81M

52.88%52.45M

-86.01%4.37M

-58.00%34.31M

--31.25M

7,932.15%81.69M

-95.37%1.02M

Cash flow from financing activities

New borrowing

-73.33%64M

-46.67%32M

--240M

--60M

----

--250M

----

Refund

60.00%-104M

17.33%-62M

-333.33%-260M

-150.00%-75M

-300.00%-60M

---30M

-216.92%-15M

----

41.89%-4.73M

39.08%-8.15M

Issuing shares

----

--150.62M

--97M

----

Interest paid - financing

-3.52%-8.5M

-37.80%-4.14M

-28.13%-8.21M

11.75%-3M

-124.10%-6.41M

-1,446.82%-3.4M

-429.44%-2.86M

---220K

46.05%-540K

33.40%-1M

Dividends paid - financing

-926.64%-53.67M

---22.84M

-445.72%-5.23M

----

75.05%-958K

66.83%-398K

-966.67%-3.84M

---1.2M

0.00%-360K

Issuance expenses and redemption of securities expenses

---89.06M

---19.36M

----

---5.37M

----

Other items of the financing business

-17.80%-6.3M

-107.48%-6.3M

---5.35M

---3.04M

----

-765.89%-375.71M

---122.29M

-502.32%-43.39M

42.36%10.79M

Net cash from financing operations

-276.05%-210.72M

-175.98%-88.82M

27.09%-56.04M

16.41%-32.18M

-452.22%-76.85M

-18.69%-38.5M

76.54%-13.92M

---32.44M

-785.51%-59.32M

55.74%-6.7M

Effect of rate

29.68%-263K

68.98%-241K

-196.83%-374K

-219.75%-777K

-110.52%-126K

-146.20%-243K

322.26%1.2M

--526K

-154.25%-539K

-263.08%-212K

Net Cash

-113.52%-11.2M

-247.54%-37.82M

439.23%82.8M

175.10%25.63M

-219.71%-24.41M

-2,763.17%-34.13M

-8.85%20.39M

---1.19M

493.65%22.37M

-182.94%-5.68M

Begining period cash

118.01%152.27M

-25.99%69.84M

29.66%94.38M

42.83%72.79M

--72.79M

-10.37%50.96M

14.00%56.86M

Cash at the end

-7.53%140.81M

20.60%114.21M

118.01%152.27M

57.82%94.7M

-25.99%69.84M

-16.80%60M

29.66%94.38M

--72.12M

42.83%72.79M

-10.37%50.96M

Cash balance analysis

Currency Unit

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(FY)Mar 31, 2024	(Q6)Sep 30, 2023	(FY)Mar 31, 2023	(Q6)Sep 30, 2022	(FY)Mar 31, 2022	(Q6)Sep 30, 2021	(FY)Mar 31, 2021	(Q6)Sep 30, 2020	(FY)Mar 31, 2020	(FY)Mar 31, 2019
Cash flow from operating activities
Earning before tax	114.43%164.89M	----	150.12%76.9M	----	-26.24%30.75M	----	-22.76%41.68M	----	-22.74%53.97M	34.79%69.85M
Profit adjustment
Interest (income) - adjustment	-180.15%-762K	----	-1,411.11%-272K	----	89.71%-18K	----	97.03%-175K	----	-157.07%-5.89M	-99.65%-2.29M
Attributable subsidiary (profit) loss	-57.73%817K	----	7.93%1.93M	----	51.01%1.79M	----	140.03%1.19M	----	37.21%-2.96M	---4.72M
Impairment and provisions:	----	----	----	----	--2.5M	----	----	----	----	--2.6M
-Impairment of trade receivables (reversal)	----	----	----	----	----	----	----	----	----	--2.6M
-Other impairments and provisions	----	----	----	----	--2.5M	----	----	----	----	----
Asset sale loss (gain):	49.13%-4.46M	----	-67,592.31%-8.77M	----	-93.40%13K	----	-16.17%197K	----	--235K	----
-Loss (gain) from sale of subsidiary company	---4.47M	----	----	----	----	----	----	----	----	----
-Loss (gain) on sale of property, machinery and equipment	-96.03%5K	----	869.23%126K	----	-93.40%13K	----	-16.17%197K	----	--235K	----
-Loss (gain) from selling other assets	----	----	---8.9M	----	----	----	----	----	----	----
Depreciation and amortization:	6.62%46.52M	----	-8.69%43.63M	----	9.59%47.78M	----	21.58%43.6M	----	20.83%35.86M	-0.47%29.68M
-Depreciation	6.62%46.52M	----	-8.69%43.63M	----	9.59%47.78M	----	21.58%43.6M	----	20.83%35.86M	-0.47%29.68M
Financial expense	3.52%8.5M	----	28.13%8.21M	----	-13.52%6.41M	----	776.80%7.41M	----	-39.21%845K	-19.79%1.39M
Special items	3,469.57%9.03M	----	--253K	----	----	----	----	----	----	----
Operating profit before the change of operating capital	84.23%224.53M	----	36.60%121.88M	----	-4.98%89.22M	----	14.44%93.9M	----	-14.98%82.05M	17.45%96.51M
Change of operating capital
Inventory (increase) decrease	-453.48%-37.02M	----	-4,810.56%-6.69M	----	-99.10%142K	----	172.81%15.76M	----	-1,748.74%-21.65M	-72.11%1.31M
Accounts receivable (increase)decrease	-162.89%-11.73M	----	680.21%18.65M	----	85.65%-3.21M	----	15.78%-22.4M	----	26.92%-26.6M	-1,124.18%-36.4M
Accounts payable increase (decrease)	54.79%35.99M	----	352.50%23.25M	----	45.57%-9.21M	----	-176.07%-16.92M	----	668.68%22.24M	-71.30%2.89M
Cash from business operations	34.81%211.77M	-1.71%62.91M	104.17%157.09M	485.01%64.01M	9.38%76.94M	-79.41%10.94M	25.51%70.35M	--53.14M	-12.86%56.05M	-31.56%64.32M
Other taxs	-79.18%-20.56M	-27.68%-2.87M	32.30%-11.47M	12.12%-2.25M	-46.20%-16.95M	-22.34%-2.56M	34.74%-11.59M	---2.09M	-139.85%-17.76M	36.60%-7.41M
Net cash from operations	31.32%191.22M	-2.78%60.04M	142.71%145.62M	636.63%61.76M	2.11%60M	-83.58%8.38M	53.47%58.76M	--51.05M	-32.73%38.29M	-30.85%56.91M
Cash flow from investment activities
Interest received - investment	180.15%762K	7,457.14%529K	1,411.11%272K	-41.67%7K	-89.71%18K	-90.77%12K	26.81%175K	--130K	500.00%138K	--23K
Sale of fixed assets	288.10%163K	----	--42K	--31K	----	----	----	----	-97.64%11K	273.60%467K
Purchase of fixed assets	-25.59%-10.21M	-140.37%-9.57M	-15.23%-8.13M	-13.41%-3.98M	69.26%-7.06M	80.77%-3.51M	-407.58%-22.96M	---18.26M	50.49%-4.52M	13.51%-9.14M
Sale of subsidiaries	--17.6M	----	----	----	----	----	----	----	----	----
Acquisition of subsidiaries	----	----	--1.86M	----	----	----	----	----	127.95%5.26M	---18.82M
Cash on investment	----	----	-61.06%-823K	----	69.36%-511K	69.36%-511K	---1.67M	---1.67M	----	----
Other items in the investment business	----	----	----	----	----	----	----	----	249.52%42.52M	42.99%-28.44M
Net cash from investment operations	222.51%8.31M	-129.28%-9.05M	10.17%-6.78M	1.65%-3.95M	69.12%-7.55M	79.74%-4.01M	-156.34%-24.45M	---19.8M	177.65%43.4M	7.33%-55.9M
Net cash before financing	43.72%199.53M	-11.79%51M	164.72%138.83M	1,222.07%57.81M	52.88%52.45M	-86.01%4.37M	-58.00%34.31M	--31.25M	7,932.15%81.69M	-95.37%1.02M
Cash flow from financing activities
New borrowing	-73.33%64M	-46.67%32M	--240M	--60M	----	----	--250M	----	----	----
Refund	60.00%-104M	17.33%-62M	-333.33%-260M	-150.00%-75M	-300.00%-60M	---30M	-216.92%-15M	----	41.89%-4.73M	39.08%-8.15M
Issuing shares	----	----	----	----	----	----	--150.62M	--97M	----	----
Interest paid - financing	-3.52%-8.5M	-37.80%-4.14M	-28.13%-8.21M	11.75%-3M	-124.10%-6.41M	-1,446.82%-3.4M	-429.44%-2.86M	---220K	46.05%-540K	33.40%-1M
Dividends paid - financing	-926.64%-53.67M	---22.84M	-445.72%-5.23M	----	75.05%-958K	66.83%-398K	-966.67%-3.84M	---1.2M	0.00%-360K	0.00%-360K
Issuance expenses and redemption of securities expenses	---89.06M	---19.36M	----	----	----	----	---5.37M	----	----	----
Other items of the financing business	-17.80%-6.3M	-107.48%-6.3M	---5.35M	---3.04M	----	----	-765.89%-375.71M	---122.29M	-502.32%-43.39M	42.36%10.79M
Net cash from financing operations	-276.05%-210.72M	-175.98%-88.82M	27.09%-56.04M	16.41%-32.18M	-452.22%-76.85M	-18.69%-38.5M	76.54%-13.92M	---32.44M	-785.51%-59.32M	55.74%-6.7M
Effect of rate	29.68%-263K	68.98%-241K	-196.83%-374K	-219.75%-777K	-110.52%-126K	-146.20%-243K	322.26%1.2M	--526K	-154.25%-539K	-263.08%-212K
Net Cash	-113.52%-11.2M	-247.54%-37.82M	439.23%82.8M	175.10%25.63M	-219.71%-24.41M	-2,763.17%-34.13M	-8.85%20.39M	---1.19M	493.65%22.37M	-182.94%-5.68M
Begining period cash	118.01%152.27M	118.01%152.27M	-25.99%69.84M	-25.99%69.84M	29.66%94.38M	29.66%94.38M	42.83%72.79M	--72.79M	-10.37%50.96M	14.00%56.86M
Cash at the end	-7.53%140.81M	20.60%114.21M	118.01%152.27M	57.82%94.7M	-25.99%69.84M	-16.80%60M	29.66%94.38M	--72.12M	42.83%72.79M	-10.37%50.96M
Cash balance analysis
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	KPMG	--	KPMG	--	KPMG	--	KPMG	--	KPMG	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

02161 JBM HEALTHCARE

JBM HEALTHCARE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target